Alverbratt C, Sandin F, Kolmbäck V, Garmo H, Bratt O, Franck Lissbrant I. Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study. AO [Internet]. 2025 Oct. 13 [cited 2026 May 1];64:1391-403. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/43794